Synopsis of recent research by authors named "De-Liang Yang"
- De-Liang Yang's research primarily focuses on the identification and evaluation of biomarkers and pharmacokinetics in relation to various autoimmune and cancer conditions, notably primary Sjögren's syndrome and advanced colorectal cancer.
- In his 2021 study, Yang identified long noncoding RNAs (lnc-DC) in plasma as potential biomarkers for primary Sjögren's syndrome, demonstrating significant associations with disease activity among patients.
- His earlier work on 5-fluorouracil drug management for advanced colorectal cancer aimed at optimizing treatment efficacy through pharmacokinetic monitoring, highlighting the importance of personalized medicine in cancer therapy.
